Lyndra Therapeutics, a Watertown-based clinical-stage biopharmaceutical company striving to make daily pills a thing of the past, recently announced that President and Chief Operating Officer Jess Ballinger has been named to the National Small Business Board of Directors. Association (NSBA), joining other advocates from across the country as they work to promote small business interests to policy makers in Washington, D.C.
Lyndra Therapeutics is a pioneer in long-acting oral therapies based on its proprietary LYNX™ Drug Delivery Platform, which has the potential to turn virtually any oral therapy into weekly or monthly pills. Lyndra focuses on central nervous system (CNS) disorders, especially conditions affecting mental health. The company is also committed to advancing its platform to address major public health and global health challenges, including opioid use disorders and malaria.
“I’m so excited about the progress our Lyndra team has made to fundamentally change the way people take their medications, but I’m equally proud of the way we do it: as a women-led company that truly embraces and understands the importance of diversity and inclusivity,” Ballinger said. “I am honored to join the NSBA Board of Directors and to be able to bring my passion for science and DE&I to this team of expert small business leaders. As the backbone of American commerce, innovation, and diverse ideas, small businesses need their voices heard in Congress — now more than ever as we continue to navigate the COVID-19 pandemic. I am thrilled to be part of this important effort.
NSBA is the nation’s oldest small business advocacy organization and operates on a decidedly non-partisan basis. Focused on addressing the many critical issues facing small businesses – including tax reform, regulatory restrictions, health care costs and the impact of access to capital on small businesses – the Governing Council also provides valuable networking opportunities among small business advocates and ensures that small businesses have a seat at the table as Congress and regulators consider key proposals.
“I am proud to have Jess Ballinger on our Board of Directors,” said NSBA President and CEO Todd McCracken. “She came highly recommended to us, and I look forward to our coordinated efforts for years to come.”
Ballinger is a senior biotechnology and pharmaceutical executive who has spent more than 25 years helping to develop and commercialize more than 15 cutting-edge therapies to meet patient needs. A local volunteer active in fundraising and in leadership roles, Ballinger has worked with Northeastern University’s Biotechnology Industry Advisory Board, the Oasis Domestic Abuse Service, and the Melanoma Education Foundation.
Ballinger enjoys cycling, running and hiking with her husband and two sons and recently completed the “vEveresting” bike challenge, raising over $8,000 for Mental Health America.
“My passion for equity, inclusivity and diversity drives everything I do, both at work and in my community,” Ballinger said. “I look forward to representing small businesses in Watertown as I engage with Congress to advocate for small businesses across the country.”